| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | potassium:chloride symporter activity | 9.17e-09 | 9 | 60 | 4 | GO:0015379 | |
| GeneOntologyMolecularFunction | ammonium channel activity | 3.58e-08 | 12 | 60 | 4 | GO:0008519 | |
| GeneOntologyMolecularFunction | chloride:monoatomic cation symporter activity | 6.25e-07 | 23 | 60 | 4 | GO:0015377 | |
| GeneOntologyMolecularFunction | monoatomic anion:monoatomic cation symporter activity | 1.05e-06 | 26 | 60 | 4 | GO:0015296 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 4.52e-04 | 119 | 60 | 4 | GO:0015294 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 5.44e-04 | 125 | 60 | 4 | GO:0015108 | |
| GeneOntologyMolecularFunction | symporter activity | 1.08e-03 | 150 | 60 | 4 | GO:0015293 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 1.10e-03 | 151 | 60 | 4 | GO:0008509 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor | 1.32e-03 | 18 | 60 | 2 | GO:0016646 | |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 1.60e-03 | 167 | 60 | 4 | GO:0015079 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 1.74e-03 | 171 | 60 | 4 | GO:0015103 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 2.09e-03 | 301 | 60 | 5 | GO:0022853 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-NH group of donors | 3.66e-03 | 30 | 60 | 2 | GO:0016645 | |
| GeneOntologyMolecularFunction | spectrin binding | 4.68e-03 | 34 | 60 | 2 | GO:0030507 | |
| GeneOntologyMolecularFunction | channel activity | 4.84e-03 | 525 | 60 | 6 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 4.88e-03 | 526 | 60 | 6 | GO:0022803 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 5.39e-03 | 118 | 60 | 3 | GO:0003774 | |
| GeneOntologyBiologicalProcess | ammonium transmembrane transport | 3.95e-08 | 13 | 58 | 4 | GO:0072488 | |
| GeneOntologyBiologicalProcess | ammonium import across plasma membrane | 8.42e-08 | 4 | 58 | 3 | GO:0140157 | |
| GeneOntologyBiologicalProcess | chloride ion homeostasis | 6.81e-07 | 25 | 58 | 4 | GO:0055064 | |
| GeneOntologyBiologicalProcess | monoatomic anion homeostasis | 1.10e-06 | 28 | 58 | 4 | GO:0055081 | |
| GeneOntologyBiologicalProcess | potassium ion homeostasis | 3.47e-06 | 37 | 58 | 4 | GO:0055075 | |
| GeneOntologyBiologicalProcess | cell volume homeostasis | 5.82e-06 | 42 | 58 | 4 | GO:0006884 | |
| GeneOntologyBiologicalProcess | potassium ion import across plasma membrane | 1.27e-05 | 51 | 58 | 4 | GO:1990573 | |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | 4.92e-05 | 142 | 58 | 5 | GO:0099587 | |
| GeneOntologyBiologicalProcess | inorganic cation import across plasma membrane | 4.92e-05 | 142 | 58 | 5 | GO:0098659 | |
| GeneOntologyBiologicalProcess | neuron development | ABLIM1 DPYSL3 KANK1 MYO6 SPHK1 EIF2AK4 TSC22D4 PBX1 PBX2 TNXB TOP2B SLC12A5 WDR47 | 1.69e-04 | 1463 | 58 | 13 | GO:0048666 |
| GeneOntologyBiologicalProcess | import into cell | SLC12A6 TGM2 ANK2 SLC12A4 LMBR1L MYO6 SPHK1 RIN2 CACNA1I SLC12A7 SLC12A5 | 1.73e-04 | 1074 | 58 | 11 | GO:0098657 |
| GeneOntologyBiologicalProcess | chloride transmembrane transport | 2.79e-04 | 112 | 58 | 4 | GO:1902476 | |
| Domain | KCL_cotranspt | 8.98e-11 | 4 | 59 | 4 | IPR000076 | |
| Domain | SLC12A_fam | 3.12e-09 | 7 | 59 | 4 | IPR004842 | |
| Domain | SLC12_C | 6.23e-09 | 8 | 59 | 4 | IPR018491 | |
| Domain | SLC12 | 6.23e-09 | 8 | 59 | 4 | PF03522 | |
| Domain | AA-permease/SLC12A_dom | 6.30e-07 | 22 | 59 | 4 | IPR004841 | |
| Domain | AA_permease | 6.30e-07 | 22 | 59 | 4 | PF00324 | |
| Domain | KCC1 | 9.81e-06 | 2 | 59 | 2 | IPR000622 | |
| Domain | PBC | 5.86e-05 | 4 | 59 | 2 | PF03792 | |
| Domain | PBX | 5.86e-05 | 4 | 59 | 2 | IPR005542 | |
| Domain | TPR-like_helical_dom | 6.28e-03 | 233 | 59 | 4 | IPR011990 | |
| Domain | Kinesin_motor_CS | 7.43e-03 | 41 | 59 | 2 | IPR019821 | |
| Domain | Kinesin-like_fam | 8.15e-03 | 43 | 59 | 2 | IPR027640 | |
| Domain | KINESIN_MOTOR_1 | 8.52e-03 | 44 | 59 | 2 | PS00411 | |
| Pathway | REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS | 2.87e-09 | 7 | 44 | 4 | M27339 | |
| Pathway | REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS | 2.87e-09 | 7 | 44 | 4 | MM15081 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 3.49e-04 | 108 | 44 | 4 | M823 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 3.62e-04 | 109 | 44 | 4 | MM15074 | |
| Pubmed | 9.15e-12 | 4 | 62 | 4 | 12637262 | ||
| Pubmed | 6.37e-10 | 8 | 62 | 4 | 11395011 | ||
| Pubmed | The WNK-regulated SPAK/OSR1 kinases directly phosphorylate and inhibit the K+-Cl- co-transporters. | 6.37e-10 | 8 | 62 | 4 | 24393035 | |
| Pubmed | Similar effects of all WNK3 variants on SLC12 cotransporters. | 6.37e-10 | 8 | 62 | 4 | 21613606 | |
| Pubmed | 1.15e-09 | 9 | 62 | 4 | 19323993 | ||
| Pubmed | 5.39e-09 | 3 | 62 | 3 | 11551954 | ||
| Pubmed | 5.39e-09 | 3 | 62 | 3 | 15262997 | ||
| Pubmed | K-Cl cotransporter gene expression during human and murine erythroid differentiation. | 5.39e-09 | 3 | 62 | 3 | 21733850 | |
| Pubmed | Rare independent mutations in renal salt handling genes contribute to blood pressure variation. | 6.54e-08 | 22 | 62 | 4 | 18391953 | |
| Pubmed | 3.00e-07 | 8 | 62 | 3 | 12386165 | ||
| Pubmed | Loss of K-Cl co-transporter KCC3 causes deafness, neurodegeneration and reduced seizure threshold. | 4.50e-07 | 9 | 62 | 3 | 14532115 | |
| Pubmed | 6.39e-07 | 407 | 62 | 8 | 12693553 | ||
| Pubmed | SLC12A6 ABLIM1 DPYSL3 ANK2 SYN3 MYO6 TRAPPC10 OGDHL DDX3Y TSC22D4 NDUFA9 SLC12A5 WDR47 | 1.16e-06 | 1431 | 62 | 13 | 37142655 | |
| Pubmed | Differences in the large extracellular loop between the K(+)-Cl(-) cotransporters KCC2 and KCC4. | 3.13e-06 | 2 | 62 | 2 | 20516068 | |
| Pubmed | Phospho-regulation, nucleotide binding and ion access control in potassium-chloride cotransporters. | 3.13e-06 | 2 | 62 | 2 | 34031912 | |
| Pubmed | Molecular, functional, and genomic characterization of human KCC2, the neuronal K-Cl cotransporter. | 3.13e-06 | 2 | 62 | 2 | 12106695 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 7910944 | ||
| Pubmed | SLC12A ion transporter mutations in sporadic and familial human congenital hydrocephalus. | 3.13e-06 | 2 | 62 | 2 | 31393094 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 17510708 | ||
| Pubmed | Pbx1 is required for adult subventricular zone neurogenesis. | 3.13e-06 | 2 | 62 | 2 | 27226325 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 10347194 | ||
| Pubmed | Genetic disruption of KCC cotransporters in a mouse model of thalassemia intermedia. | 3.13e-06 | 2 | 62 | 2 | 31835175 | |
| Pubmed | Targeting SPHK1/PBX1 Axis Induced Cell Cycle Arrest in Non-Small Cell Lung Cancer. | 3.13e-06 | 2 | 62 | 2 | 36361531 | |
| Pubmed | 3.81e-06 | 233 | 62 | 6 | 29518331 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 31352162 | ||
| Pubmed | The TALE homeodomain protein Pbx2 is not essential for development and long-term survival. | 9.37e-06 | 3 | 62 | 2 | 15169896 | |
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 17133354 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 35274823 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 22252133 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 11468159 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 9482739 | ||
| Pubmed | Molecular evidence for a role for K(+)-Cl(-) cotransporters in the kidney. | 9.37e-06 | 3 | 62 | 2 | 24089410 | |
| Pubmed | Molecular physiology of cation-coupled Cl- cotransport: the SLC12 family. | 9.37e-06 | 3 | 62 | 2 | 12739168 | |
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 10679934 | ||
| Pubmed | Ammonium transport and pH regulation by K(+)-Cl(-) cotransporters. | 9.37e-06 | 3 | 62 | 2 | 12657561 | |
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 12609849 | ||
| Pubmed | 1.07e-05 | 76 | 62 | 4 | 10574461 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | SLC12A6 ABLIM1 MYO6 RIN2 TMC6 ZG16B EIF2AK4 TSC22D4 PBX1 PBX2 BAIAP3 SH3RF3 | 1.08e-05 | 1489 | 62 | 12 | 28611215 |
| Pubmed | PBX1 acts as terminal selector for olfactory bulb dopaminergic neurons. | 1.87e-05 | 4 | 62 | 2 | 32156753 | |
| Pubmed | Pbx/Meis deficiencies demonstrate multigenetic origins of congenital heart disease. | 1.87e-05 | 4 | 62 | 2 | 18723445 | |
| Pubmed | PBX2 and PBX3, new homeobox genes with extensive homology to the human proto-oncogene PBX1. | 1.87e-05 | 4 | 62 | 2 | 1682799 | |
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 8661110 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 3.11e-05 | 202 | 62 | 5 | 33005030 | |
| Pubmed | Sites of regulated phosphorylation that control K-Cl cotransporter activity. | 3.12e-05 | 5 | 62 | 2 | 19665974 | |
| Pubmed | 3.12e-05 | 5 | 62 | 2 | 10842069 | ||
| Pubmed | 3.12e-05 | 5 | 62 | 2 | 18973687 | ||
| Pubmed | Pbx4, a new Pbx family member on mouse chromosome 8, is expressed during spermatogenesis. | 3.12e-05 | 5 | 62 | 2 | 11335119 | |
| Pubmed | HOXA9 forms triple complexes with PBX2 and MEIS1 in myeloid cells. | 3.12e-05 | 5 | 62 | 2 | 10082572 | |
| Pubmed | Transcription factor PBX4 regulates limb development and haematopoiesis in mice. | 3.12e-05 | 5 | 62 | 2 | 38230761 | |
| Pubmed | 4.67e-05 | 6 | 62 | 2 | 19559479 | ||
| Pubmed | The PBX-regulating protein PREP1 is present in different PBX-complexed forms in mouse. | 4.67e-05 | 6 | 62 | 2 | 10381567 | |
| Pubmed | 4.67e-05 | 6 | 62 | 2 | 37414772 | ||
| Pubmed | 4.67e-05 | 6 | 62 | 2 | 28647557 | ||
| Pubmed | Characterization of TALE genes expression during the first lineage segregation in mammalian embryos. | 4.67e-05 | 6 | 62 | 2 | 22987645 | |
| Pubmed | Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration. | 6.04e-05 | 558 | 62 | 7 | 35063084 | |
| Pubmed | 6.53e-05 | 7 | 62 | 2 | 17178831 | ||
| Pubmed | 6.53e-05 | 7 | 62 | 2 | 15813942 | ||
| Pubmed | 6.53e-05 | 7 | 62 | 2 | 12397630 | ||
| Pubmed | A Pbx1-dependent genetic and transcriptional network regulates spleen ontogeny. | 6.53e-05 | 7 | 62 | 2 | 15944191 | |
| Pubmed | Purification of the Prep1 interactome identifies novel pathways regulated by Prep1. | 6.53e-05 | 7 | 62 | 2 | 17623278 | |
| Pubmed | 8.69e-05 | 8 | 62 | 2 | 20541704 | ||
| Pubmed | 8.69e-05 | 8 | 62 | 2 | 31625560 | ||
| Pubmed | Bone morphology is regulated modularly by global and regional genetic programs. | 1.12e-04 | 9 | 62 | 2 | 31221640 | |
| Pubmed | A highly conserved molecular switch binds MSY-3 to regulate myogenin repression in postnatal muscle. | 1.12e-04 | 9 | 62 | 2 | 18676817 | |
| Pubmed | Meis homeoproteins directly regulate Pax6 during vertebrate lens morphogenesis. | 1.12e-04 | 9 | 62 | 2 | 12183364 | |
| Pubmed | Expression of Hox cofactor genes during mouse ovarian follicular development and oocyte maturation. | 1.12e-04 | 9 | 62 | 2 | 15087118 | |
| Pubmed | 1.12e-04 | 52 | 62 | 3 | 22219177 | ||
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | 1.18e-04 | 621 | 62 | 7 | 22794259 | |
| Pubmed | 1.34e-04 | 634 | 62 | 7 | 34591612 | ||
| Pubmed | Hox and Pbx factors control retinoic acid synthesis during hindbrain segmentation. | 1.39e-04 | 10 | 62 | 2 | 21497760 | |
| Pubmed | 1.39e-04 | 10 | 62 | 2 | 16515781 | ||
| Pubmed | 1.39e-04 | 10 | 62 | 2 | 29797482 | ||
| Pubmed | A unique stylopod patterning mechanism by Shox2-controlled osteogenesis. | 1.39e-04 | 10 | 62 | 2 | 27287812 | |
| Pubmed | Protein Binder Toolbox for Studies of Solute Carrier Transporters. | 1.40e-04 | 56 | 62 | 3 | 38878854 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 1.42e-04 | 861 | 62 | 8 | 36931259 | |
| Pubmed | 1.70e-04 | 11 | 62 | 2 | 29437830 | ||
| Pubmed | 2.04e-04 | 12 | 62 | 2 | 27782176 | ||
| Pubmed | A TALE/HOX code unlocks WNT signalling response towards paraxial mesoderm. | 2.04e-04 | 12 | 62 | 2 | 34446717 | |
| Pubmed | Hypoxia regulates Hippo signalling through the SIAH2 ubiquitin E3 ligase. | 2.04e-04 | 12 | 62 | 2 | 25438054 | |
| Pubmed | 2.04e-04 | 12 | 62 | 2 | 20573694 | ||
| Pubmed | 2.04e-04 | 12 | 62 | 2 | 20627960 | ||
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | 2.31e-04 | 925 | 62 | 8 | 28986522 | |
| Pubmed | 2.41e-04 | 13 | 62 | 2 | 16847320 | ||
| Pubmed | Pax6 is regulated by Meis and Pbx homeoproteins during pancreatic development. | 2.41e-04 | 13 | 62 | 2 | 17049510 | |
| Pubmed | 2.41e-04 | 13 | 62 | 2 | 16438966 | ||
| Pubmed | Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair. | 2.73e-04 | 321 | 62 | 5 | 32098917 | |
| Pubmed | Control of pelvic girdle development by genes of the Pbx family and Emx2. | 2.81e-04 | 14 | 62 | 2 | 21455939 | |
| Pubmed | 2.81e-04 | 14 | 62 | 2 | 15570572 | ||
| Pubmed | 3.23e-04 | 15 | 62 | 2 | 30071041 | ||
| Pubmed | 3.23e-04 | 15 | 62 | 2 | 23756022 | ||
| Pubmed | Combinatorial CRISPR screen identifies fitness effects of gene paralogues. | 3.47e-04 | 186 | 62 | 4 | 33637726 | |
| Pubmed | Ecm29-mediated proteasomal distribution modulates excitatory GABA responses in the developing brain. | 4.70e-04 | 18 | 62 | 2 | 31910261 | |
| Pubmed | 4.70e-04 | 18 | 62 | 2 | 26904955 | ||
| Pubmed | PBX transcription factors drive pulmonary vascular adaptation to birth. | 5.24e-04 | 19 | 62 | 2 | 29251627 | |
| Pubmed | 6.42e-04 | 21 | 62 | 2 | 23650387 | ||
| Pubmed | 7.06e-04 | 22 | 62 | 2 | 22748019 | ||
| Pubmed | 7.09e-04 | 225 | 62 | 4 | 12168954 | ||
| Pubmed | 7.67e-04 | 403 | 62 | 5 | 30562941 | ||
| Pubmed | 7.72e-04 | 23 | 62 | 2 | 30779601 | ||
| Pubmed | 7.72e-04 | 23 | 62 | 2 | 16672333 | ||
| Interaction | MS4A15 interactions | 5.40e-06 | 39 | 60 | 4 | int:MS4A15 | |
| Interaction | FAM222A interactions | 7.02e-06 | 13 | 60 | 3 | int:FAM222A | |
| Interaction | LGALS9B interactions | 9.65e-06 | 45 | 60 | 4 | int:LGALS9B | |
| Interaction | GPM6A interactions | 1.06e-05 | 168 | 60 | 6 | int:GPM6A | |
| Interaction | SLC17A2 interactions | 2.32e-05 | 56 | 60 | 4 | int:SLC17A2 | |
| Interaction | SLC12A5 interactions | 3.21e-05 | 21 | 60 | 3 | int:SLC12A5 | |
| Interaction | ZDHHC12 interactions | 3.26e-05 | 123 | 60 | 5 | int:ZDHHC12 | |
| Interaction | POPDC2 interactions | 4.26e-05 | 23 | 60 | 3 | int:POPDC2 | |
| Interaction | LYN interactions | NPHS1 SLC12A6 ABLIM1 ANK2 SLC12A4 DSG1 MYO6 SPHK1 SLC12A7 TOP2B | 4.77e-05 | 720 | 60 | 10 | int:LYN |
| Interaction | OR10H2 interactions | 6.28e-05 | 72 | 60 | 4 | int:OR10H2 | |
| Interaction | CLRN2 interactions | 7.76e-05 | 76 | 60 | 4 | int:CLRN2 | |
| Interaction | RGS14 interactions | 7.84e-05 | 240 | 60 | 6 | int:RGS14 | |
| Interaction | TMC4 interactions | 9.62e-05 | 30 | 60 | 3 | int:TMC4 | |
| Interaction | PIGH interactions | 1.17e-04 | 161 | 60 | 5 | int:PIGH | |
| Interaction | RAB39A interactions | 1.28e-04 | 33 | 60 | 3 | int:RAB39A | |
| Interaction | RXFP1 interactions | 1.50e-04 | 90 | 60 | 4 | int:RXFP1 | |
| Interaction | LGALS9C interactions | 1.53e-04 | 35 | 60 | 3 | int:LGALS9C | |
| GeneFamily | TALE class homeoboxes and pseudogenes | 1.50e-03 | 26 | 40 | 2 | 526 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 4.64e-03 | 46 | 40 | 2 | 622 | |
| GeneFamily | Solute carriers | 1.10e-02 | 395 | 40 | 4 | 752 | |
| GeneFamily | PHD finger proteins | 1.69e-02 | 90 | 40 | 2 | 88 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.08e-07 | 195 | 62 | 6 | ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2 | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 5.96e-06 | 185 | 62 | 5 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.28e-06 | 187 | 62 | 5 | e35716f8b482be3bf5ab79f087a9caf67a9d197a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.44e-06 | 188 | 62 | 5 | d9692b6048d9b85524a07a1807bdd4757731c151 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.61e-06 | 189 | 62 | 5 | 42ab4cc5fbf8580841f31889446fe4499df1a464 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.61e-06 | 189 | 62 | 5 | 37ecbd73408d462b47d7e5611f203143e08a2689 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.78e-06 | 190 | 62 | 5 | 07f21386ea6eb23416a537d2250e3042efe93fb0 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.78e-06 | 190 | 62 | 5 | ae97df1b06bcd46c05759b53c35dc8fea97f4ac1 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.96e-06 | 191 | 62 | 5 | 2b056cbe2e82e056e1f798974999378460eb1d16 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.96e-06 | 191 | 62 | 5 | a90c8ab2077e52bbc998457c85a1b9867f9c8c93 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.96e-06 | 191 | 62 | 5 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.14e-06 | 192 | 62 | 5 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | Control-PLT_1|World / Disease Group and Platelet Clusters | 7.14e-06 | 192 | 62 | 5 | f595eba81911eb860dce964f1d8269287f50d3ea | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.89e-06 | 196 | 62 | 5 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | nucseq-Endothelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.08e-06 | 197 | 62 | 5 | ebf9be068eaa658493fa7884fd19f34642922acb | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-D|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 8.28e-06 | 198 | 62 | 5 | fd14efd8e6c74a04bde985c08dc34217c0ef1bab | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.28e-06 | 198 | 62 | 5 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 8.28e-06 | 198 | 62 | 5 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-2,_SCARA5|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 8.70e-06 | 200 | 62 | 5 | ef30f9b68bfdb8d947ed399603e4dd0d5ff0144d | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-2,_SCARA5-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.70e-06 | 200 | 62 | 5 | b28bfe6eb96b4db9cb27f0fc8fc39259c125f05e | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-2,_SCARA5|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.70e-06 | 200 | 62 | 5 | 87953ea65ff2a01485e13dd49d993ae6ae679cbf | |
| ToppCell | Control-Fibroblasts-Mesothelial_FB|Control / group, cell type (main and fine annotations) | 4.23e-05 | 139 | 62 | 4 | e769beb031b262dd92c9605b07dbf3c29fb82520 | |
| ToppCell | Lymphoid-Lymphoid-T_cells_(Cd4+_Tnaive-Tcm)|Lymphoid / shred on cell class and cell subclass (v4) | 6.15e-05 | 153 | 62 | 4 | ffb8ac88513e83d3ba01574e60beb5476154372b | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Junb_(Mural,_IEG+)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 6.63e-05 | 156 | 62 | 4 | 029ba0832ee9c4a2c85620e4df2260e02d86b45c | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Junb_(Mural,_IEG+)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 6.63e-05 | 156 | 62 | 4 | 5df19a235843829f5a1a90ca21b0964ef8b4e115 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.64e-05 | 167 | 62 | 4 | f01b96173deda0239fa482989873cf308e49d48c | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.64e-05 | 167 | 62 | 4 | 5fc85a05124cd2324e1b8ff940193880f83cd8af | |
| ToppCell | control-Myeloid-pDC|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.84e-05 | 168 | 62 | 4 | affc39c7568b7df4b36af6f5b0e3702a18b6268c | |
| ToppCell | droplet-Pancreas-Exocrine-18m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.04e-05 | 169 | 62 | 4 | 53690d6f9712b54aa99a0408aae930d64ae478e5 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.25e-05 | 170 | 62 | 4 | 6035c92cd39c5ac54e7ec57d94888ee19f574639 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.25e-05 | 170 | 62 | 4 | c8c42eda44b61440c96b202e7f54650046eb95d3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.25e-05 | 170 | 62 | 4 | dcc64b73134e89ae37990d4878813b86ce91dae9 | |
| ToppCell | normal_Lung-T/NK_cells-CD8+/CD4+_Mixed_Th|T/NK_cells / Location, Cell class and cell subclass | 9.68e-05 | 172 | 62 | 4 | 0657c736f3c52d25cf7f652eac005ddcde9232ef | |
| ToppCell | Monocytes-IFN-activated_Monocytes|Monocytes / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.06e-04 | 176 | 62 | 4 | 6a4b403ee3e4dc4f23fbd7a154011e41fd429a9e | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.06e-04 | 176 | 62 | 4 | bfea433544c6d6b8ad55e50ca94c5574460c2e0b | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-neurons_B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.06e-04 | 176 | 62 | 4 | 3c78dee7e1111a579fde6d401b9ecb4d5b8e782f | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-04 | 177 | 62 | 4 | 227d4f423b00be2e0c5797e2c5275d342e69a0f4 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-04 | 177 | 62 | 4 | 66ffa279147961080c104242a08b176e301d80e3 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-04 | 177 | 62 | 4 | 0cbf54608d2ba0a0500af142f2029fe5e118c3c2 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.15e-04 | 180 | 62 | 4 | 01f2e5d96016823482f89ba503d007d4bd88eeac | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.15e-04 | 180 | 62 | 4 | 27e8bbee388e64dd79d70b160b76d45b1f398006 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.20e-04 | 182 | 62 | 4 | 3cc61f5f7ad4a81eba3daf65e122880b5af3adc0 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.20e-04 | 182 | 62 | 4 | 5d909e4b5f662905bf1be9c686bbddc3e87d2be9 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.28e-04 | 185 | 62 | 4 | efc5d564f8793c751ba640aef60f761e4b081d3f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.28e-04 | 185 | 62 | 4 | b5277190866d9eb5b85eceaa5ba116ea6e6f286b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.28e-04 | 185 | 62 | 4 | 2e1766f1a972fecd670daaaf7eb2d3a404f121e7 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.28e-04 | 185 | 62 | 4 | 7aaa8335b40927e3e8fdcede807cd521fc213a0d | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.28e-04 | 185 | 62 | 4 | fba2dc46cd98ab9c78e788959c2121aa10d148b2 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-04 | 185 | 62 | 4 | 4d0f3d86fab02c80093e62cb0c79c586c13c5412 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.34e-04 | 187 | 62 | 4 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-04 | 187 | 62 | 4 | 97e520705491c8f52a32025311a9fa7b9176979a | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Adult / Lineage, Cell type, age group and donor | 1.36e-04 | 188 | 62 | 4 | e5cad03f4a64147fe8174e7f614cf45233ffb9b7 | |
| ToppCell | Control-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations) | 1.36e-04 | 188 | 62 | 4 | 706a26c372add839d947749f0521a0e1f5c9b0ec | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.36e-04 | 188 | 62 | 4 | 505b6b4277d7dea87aee27191d0acca67928b8e6 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.36e-04 | 188 | 62 | 4 | c4c3b21ab723b0e9beff9ec84f8d68485f771528 | |
| ToppCell | Control-Endothelial_cells|Control / group, cell type (main and fine annotations) | 1.36e-04 | 188 | 62 | 4 | 3953b08abfea93468fc8d177bdb16ca7c6ffa1ab | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.39e-04 | 189 | 62 | 4 | b6b4da51bc7f2c13a2f940540fdc61027d084835 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.39e-04 | 189 | 62 | 4 | 784ace2be87f2ecb19490f4974f63a559516e0eb | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.42e-04 | 190 | 62 | 4 | 7dcca3469f3a3b70db0420cb94f7765f39492f06 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.42e-04 | 190 | 62 | 4 | 2de8e4cfeee350a9a76af749d6ce58d948c129b8 | |
| ToppCell | IPF-Endothelial-VE_Capillary_A|IPF / Disease state, Lineage and Cell class | 1.42e-04 | 190 | 62 | 4 | b4e35cbfe4d43d2cd51f29c3085e4d9b1012e6f0 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.42e-04 | 190 | 62 | 4 | 0fea33f2dc1efa23aaa2da1c318482a52a313ff1 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 1.42e-04 | 190 | 62 | 4 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.45e-04 | 191 | 62 | 4 | f5ce33af56178333730be308253943c54a0724cf | |
| ToppCell | Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.45e-04 | 191 | 62 | 4 | 1de0bdfd13bd930691564c2673f2e66393bc0255 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.45e-04 | 191 | 62 | 4 | 2110a1dd10730ad7ee7a265fb1716ab3ddafcf4a | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.45e-04 | 191 | 62 | 4 | f229abf69a1217194f74b0502486907e07dba989 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.45e-04 | 191 | 62 | 4 | f3158cedf67e3b90aa94ea1f61c72c33aaa2d5ba | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 191 | 62 | 4 | a251b134f67a0a1ef3a42f50042f128a17f20b22 | |
| ToppCell | Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|World / Lineage, Cell type, age group and donor | 1.48e-04 | 192 | 62 | 4 | 1e156bab5ecf64627890d2de9b27603d9a01f28d | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.48e-04 | 192 | 62 | 4 | a8b7c539dc3037071bf068f372e4215563e11de4 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell-Papillary_Tip_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-04 | 192 | 62 | 4 | 612be3f861bd2f71a31c57f48c8b10930c3471ea | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-04 | 192 | 62 | 4 | 2510f22197502f60fd266b7f42eff040f25b8ae7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-04 | 192 | 62 | 4 | e8e316f396834bcd34843e56e1d86f310fd6aada | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-04 | 192 | 62 | 4 | f627a3f43e2340c8ba502211940171f25c7ff436 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell|Adult / Lineage, Cell type, age group and donor | 1.48e-04 | 192 | 62 | 4 | d21f0f577156f17c899b08871046a26b88aea011 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.48e-04 | 192 | 62 | 4 | 2143e1fad2e88b90d668e12af37b2092d379090f | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.48e-04 | 192 | 62 | 4 | 904c003c4f73b1dfc8243cee02aad2676c515e50 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.51e-04 | 193 | 62 | 4 | f582e939e3e08a8a3f71deec78c33715be8faa51 | |
| ToppCell | LAM-Endothelial-LymEndo|LAM / Condition, Lineage and Cell class | 1.51e-04 | 193 | 62 | 4 | 68eadc91c2d89edd2412e86dfe134dd7c0ef6ee9 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.51e-04 | 193 | 62 | 4 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Proximal_secretory_1|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.51e-04 | 193 | 62 | 4 | 0ef076417ffe2dd1cbc2c3d1e35c7f8522af143b | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.51e-04 | 193 | 62 | 4 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | COPD-Endothelial|COPD / Disease state, Lineage and Cell class | 1.51e-04 | 193 | 62 | 4 | 093b28dcccb5841c995d0b33fae0efd6b88f97e0 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 1.51e-04 | 193 | 62 | 4 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-04 | 193 | 62 | 4 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.51e-04 | 193 | 62 | 4 | 9ab47b360bee1d4f1092c2269e58acebe9584021 | |
| ToppCell | PND01|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.51e-04 | 193 | 62 | 4 | c291345c11cfcbceacbdc001a5851f67478a2779 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.54e-04 | 194 | 62 | 4 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-04 | 194 | 62 | 4 | b490fffc94f005dff9a34ce34d80ca776e3a1387 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-04 | 194 | 62 | 4 | fa6d51f36a3dae8763a595c20892987ed454c0f0 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.57e-04 | 195 | 62 | 4 | d7e92bcbd05b93e86a1e1397e44ad27a9e2e637a | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 1.57e-04 | 195 | 62 | 4 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.57e-04 | 195 | 62 | 4 | 6095bb237d7bc75cbaeaeb492f6948f3c3fa4848 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.60e-04 | 196 | 62 | 4 | 686533fd3fba8e4df96b9dd1307e870e89db4332 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Squamous|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.60e-04 | 196 | 62 | 4 | 97e16d9833e4083d719ca7058d5fc9b11edb37e3 | |
| ToppCell | 368C|World / Donor, Lineage, Cell class and subclass (all cells) | 1.63e-04 | 197 | 62 | 4 | f41211923938e5d7bfe6bf24f604ab386f17ef10 | |
| ToppCell | COVID-19-Epithelial-Club,_Basal_cells|Epithelial / Condition, Lineage and Cell class | 1.63e-04 | 197 | 62 | 4 | 78ed2810e5a765327e7a6da0ca5d4854bf7a0b6f | |
| ToppCell | Bronchial_Brush-Epithelial-Club|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.66e-04 | 198 | 62 | 4 | 61292a2b5aacb6080a679a31b70a211bdec59a3b | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.66e-04 | 198 | 62 | 4 | fb3965049cb1961de0d2e74370868e46aa5050c8 | |
| Drug | Potassium Chloride | 6.97e-10 | 6 | 61 | 4 | DB00761 | |
| Drug | 8-bromoguanosine 3',5'-cyclic monophosphate | 1.62e-06 | 308 | 61 | 8 | CID000001915 | |
| Drug | DCPIB | 2.97e-06 | 11 | 61 | 3 | CID010071166 | |
| Drug | ((2-n-butyl-6,7-dichloro-2-cyclopentyl-2,3-dihydro-1-oxo-1H-inden-5-yl)oxy)acetic acid | 7.06e-06 | 2 | 61 | 2 | ctd:C095651 | |
| Drug | Bumetanide | 1.00e-05 | 16 | 61 | 3 | ctd:D002034 | |
| Drug | Ganciclovir [82410-32-0]; Up 200; 15.6uM; MCF7; HT_HG-U133A | 1.41e-05 | 196 | 61 | 6 | 3368_UP | |
| Drug | Cephalexin monohydrate [23325-78-2]; Up 200; 11uM; MCF7; HT_HG-U133A | 1.45e-05 | 197 | 61 | 6 | 5250_UP | |
| Drug | Viomycin sulfate [37883-00-4]; Up 200; 5.2uM; HL60; HT_HG-U133A | 1.50e-05 | 198 | 61 | 6 | 2979_UP | |
| Drug | Asiaticoside [16830-15-2]; Down 200; 4.2uM; PC3; HT_HG-U133A | 1.50e-05 | 198 | 61 | 6 | 7244_DN | |
| Drug | NSC611747 | 4.24e-05 | 352 | 61 | 7 | CID000002534 | |
| Disease | epilepsy (implicated_via_orthology) | 2.43e-05 | 163 | 62 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | urate measurement, bone density | 3.13e-04 | 619 | 62 | 7 | EFO_0003923, EFO_0004531 | |
| Disease | lean mass-adjusted fat body mass | 6.50e-04 | 18 | 62 | 2 | EFO_0009890 | |
| Disease | Chronic myeloproliferative disorder | 7.26e-04 | 19 | 62 | 2 | C1292778 | |
| Disease | Seckel syndrome | 9.77e-04 | 22 | 62 | 2 | C0265202 | |
| Disease | osteoporosis (biomarker_via_orthology) | 9.77e-04 | 22 | 62 | 2 | DOID:11476 (biomarker_via_orthology) | |
| Disease | mean reticulocyte volume | 1.40e-03 | 799 | 62 | 7 | EFO_0010701 | |
| Disease | lean mass-adjusted fat body mass, femoral neck bone mineral density | 1.47e-03 | 27 | 62 | 2 | EFO_0007785, EFO_0009890 | |
| Disease | reticulocyte count | 1.50e-03 | 1045 | 62 | 8 | EFO_0007986 | |
| Disease | Drug habituation | 1.84e-03 | 115 | 62 | 3 | C0013170 | |
| Disease | Substance-Related Disorders | 1.84e-03 | 115 | 62 | 3 | C0236969 | |
| Disease | Drug abuse | 1.84e-03 | 115 | 62 | 3 | C0013146 | |
| Disease | Drug Use Disorders | 1.84e-03 | 115 | 62 | 3 | C0013222 | |
| Disease | Drug Dependence | 1.84e-03 | 115 | 62 | 3 | C1510472 | |
| Disease | Substance Dependence | 1.84e-03 | 115 | 62 | 3 | C0038580 | |
| Disease | Substance Use Disorders | 1.84e-03 | 115 | 62 | 3 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 1.84e-03 | 115 | 62 | 3 | C0029231 | |
| Disease | Prescription Drug Abuse | 1.84e-03 | 115 | 62 | 3 | C4316881 | |
| Disease | Substance abuse problem | 1.89e-03 | 116 | 62 | 3 | C0740858 | |
| Disease | obsolete_red blood cell distribution width | 1.92e-03 | 1347 | 62 | 9 | EFO_0005192 | |
| Disease | Squamous cell carcinoma of lung | 2.07e-03 | 32 | 62 | 2 | C0149782 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DHSGMLVMLPFDLRI | 1106 | Q9P2K8 | |
| LPDGHMPAMRMDRGV | 691 | O14639 | |
| PGDGVEFFAHMRLML | 81 | O94812 | |
| EMLDAMLKALHPRGI | 1446 | Q9UIF9 | |
| RMLEMGITGPEGHVL | 211 | Q14195 | |
| LGLDPGLDHMLAMET | 601 | Q9UDR5 | |
| RPKHMRVMAGALEGD | 41 | P42025 | |
| GIQMLMGRLEDGSHL | 151 | Q14406 | |
| MPLGHIMRLDLEKIA | 1 | Q9H6Z9 | |
| RHRLATMPPMVEGEG | 1011 | Q01484 | |
| LLPMEETVMDGLHGG | 381 | O60500 | |
| MRLDNMLLAEGVAGP | 106 | P40424 | |
| MRLDNMLLAEGVAGP | 116 | P40425 | |
| DMDLLHRVVAPGVRM | 1631 | Q9H6A9 | |
| EMGIENVILGMPHRG | 286 | Q9ULD0 | |
| PLGMMTGLDHYIERI | 816 | Q14678 | |
| PEEVHGRHGLSMEIM | 181 | Q96EZ4 | |
| MDEPRAIALHPEMGL | 76 | A4QPB2 | |
| IMHLRPMGDLGQLLF | 91 | Q16795 | |
| DLHGMLEMPDLRDGS | 876 | Q02413 | |
| LDYMEELGMLLGGRP | 396 | P0DPD8 | |
| MGEHGLELASMIPAL | 1 | Q13535 | |
| PEGKNMLIHGRAMLL | 1991 | Q13535 | |
| IHEIQRFGDMLPMGL | 356 | Q16696 | |
| RFGDMLPMGLAHRVN | 361 | Q16696 | |
| DELRMEPLGLEGLNM | 656 | Q53ET0 | |
| MDAELELEMAHGLGP | 1746 | Q9P0X4 | |
| MEMELLRFGGTPIHF | 426 | P51841 | |
| MVGERHAGDLMVPLG | 1 | Q8IWT3 | |
| IHMDMTEIDPAKGGR | 5886 | Q8NDH2 | |
| DSKEHLAMMERILGP | 381 | Q9HAZ1 | |
| HLLVATPGRLVDMME | 316 | O15523 | |
| IVHDGGMLMLLPFLL | 916 | Q9UHW9 | |
| IVHDGGMLMLLPFLL | 851 | Q9Y666 | |
| MMGSEDHLGVIPRAI | 96 | Q02224 | |
| DTMHILVDGEDMGPA | 1046 | Q96JN8 | |
| HDGGMLMLLPFLLRH | 856 | Q9H2X9 | |
| SMMGHAEQLGLIPRL | 111 | Q9H1H9 | |
| MPLIGEHVEEDRQLM | 371 | O14994 | |
| NVRRMLDGLDPHPML | 896 | Q02880 | |
| RLRMELGAPEEMGQV | 241 | Q9Y3Q8 | |
| ILELLIDEAAMPRGM | 321 | Q6UX01 | |
| EMLRMGIHIPDRDAA | 216 | Q9BWX1 | |
| PGRHMDMLTAADRLP | 1131 | Q6ZUB1 | |
| KSGEEGMPDLAHVMR | 326 | O75688 | |
| IVHDGGMLMLLPFLL | 851 | Q9UP95 | |
| GLLEHVLAMEMAPLG | 411 | Q7Z7M1 | |
| MVLAMLGALHPRAGL | 1 | C9JXX5 | |
| EEVKVRMDLLPLHMG | 646 | P21980 | |
| MMELLDPSLLHGEGG | 721 | Q8WYP3 | |
| MHDGTIRDLAFMEGP | 706 | O94967 | |
| GESPGMHRPEAMLLL | 26 | Q96DA0 | |
| EMLAHGGGREPMLMV | 666 | Q99797 | |
| DLAHMGRSREDPAGM | 151 | Q9BRG2 | |
| MGMEPLHRKAGSLDL | 786 | Q8TEJ3 | |
| GEEVPTIEGMRMHLL | 746 | P22105 | |
| EDMVGRPLPHLAADM | 571 | P47989 | |
| MPIAMLLHTDGEHER | 221 | Q9H903 | |
| LYDLLIAPMEGGLMH | 1396 | Q96AY4 | |
| PDGVRIMHSLGLMLS | 776 | Q9ULT0 | |
| DGLMHEVVNGLMERP | 81 | Q9NYA1 | |
| RDHMLRGMPLSLAEK | 161 | Q7Z403 | |
| LGGESDMLGMAEPHR | 891 | P48553 | |
| MIGEEPLDHLLGMRA | 1006 | Q6ZQQ6 | |
| MKDPLLDDHGDFIRM | 306 | Q9UM54 |